Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Irritation and Sensitization Study of Estradiol/Levonorgestrel Transdermal System
NCT07794150Phase 1Recruiting
- Sponsor
- Corium
- Start
- Aug 2026
- Primary completion
- May 2027
- Countries
- 2
01
Overview
Phase 1, randomised, single-blind trial of estradiol and avatrombopag in menopause (2 arms), sponsored by Corium. Primary endpoints: Mean Irritation Score at Day 22 and Number of Participants With a Potential Sensitization Response. Started Aug 2026; status: recruiting.
02
Drugs
estradiolavatrombopag
03
Conditions
menopause
Beyond the preview
Go deeper on NCT07794150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07794150.